Breast Cancer Survivorship and Supportive Care International Conference

Nov. 28-29, 2025 / The Westin Harbour Castle, Toronto

Industry Symposium

Bridging Evidence and Experience: Building the New Normal in HR+/HER2– Early Breast Cancer Survivorship

Friday Nov. 28, 12:15-13:00

Speakers

Nancy Nixon (Chair)

Nancy Nixon (Chair) MD, FRCPC (Chair)
Medical Oncologist Arthur Child Cancer Centre
Assistant Professor University of Calgary
Southern Alberta Tumour Team Lead in Breast Oncology
Calgary, MB

Mary DeCarolis MD, MCFP, CFE
General Practitioner in Oncology,
Grand River Regional Cancer Centre
Kitchener, ON

Mary Youssef

Mary Youssef BPharm, RPh, PhD
Oncology Resource Pharmacist,
Trillium Health Partners
Mississauga, ON

Objectives

  • Integrate emerging evidence and clinical experience with adjuvant CDK4/6 inhibitors to optimize survivorship care in HR+/HER2– early breast cancer.
  • Examine multidisciplinary and innovative care models that encourage continuity, communication, and empowerment across the survivorship journey.
  • Implement collaborative, patient-centered strategies that strengthen adherence and quality of life for persons with HR+/HER2– early breast cancer.

Fertility after Breast Cancer: When, Who, How?

Saturday Nov. 29, 12:15-13:00

Speakers

Karen Glass

Karen Glass MD, FRCS(C)

Born in Toronto, Dr. Glass attended the Ontario Science Centre Science School. She then took her undergraduate training at University of Western Ontario, her medical training at University of Ottawa and her postgraduate training in Obstetrics and Gynecology at McMaster University in Hamilton, Ontario.

Karen Glass

Dr. Glass’ interest in laparoscopic and hysteroscopic surgery brought her to Los Angeles and UCLA where she had a dual appointment in the divisions of REI and Urogynecology. She worked with David Meldrum’s team at Reproductive Partners Medical Group for the REI part of her training.

In 1999, she returned to Canada as Assistant Professor at McMaster University. In 2002, Dr. Glass moved to Toronto to concentrate her efforts on REI and specifically Fertility Preservation in oncology patients. She joined the CReATe Fertility Centre. She is their Director of Fertility Preservation. She is on staff at Sunnybrook Health Sciences Centre and Women’s College Hospital. She is an Associate Professor at University of Toronto. She served on the executive of the Fertility Preservation Special Interest Group of the ASRM for 5 years (2009-2014). She is currently the Past Chair of the FP Special Interest Group of CFAS. She received a prestigious grant as a co-investigator from CIHR and CBCF to study young women with breast cancer (RUBY Study). She sat on the Oncofertility Working Group for Adolescent and Young Adult Oncology. This is part of Canadian Partnership Against Cancer (CPAC). She sits on the Medical Advisory Panel of Fertile Future. In October 2015, Fertile Future honoured Dr. Glass for her work with young people with cancer. Dr. Glass has spoken all over Canada on Oncofertility. She sees young cancer patients from all over Ontario who require consultation and help regarding fertility preservation.

Objectives

  • Understand the options for fertility post Breast Cancer
  • Discuss fertility timing and management options for Breast cancer survivors
  • Review the specific issues in patients with a BRCA pathogenic variant